Biotinylated Cynomolgus Her2 / ErbB2 Protein, Fc, Avi Tag

<strong>Biotinylated Cynomolgus Her2 / ErbB2 Protein, Fc, Avi Tag </strong> <strong>Catalog number:</strong> B2024504 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> 97.5 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> ERBB2, CD340, HER-2, neu, HER2, MLN19, NEU, NGL, TKR1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. J., et al. (2018). "Biotinylated Cynomolgus Her2/ErbB2 Protein: A Novel Tool for Targeted Drug Delivery in Cancer Therapy." *Journal of Cancer Research and Clinical Oncology*, 144(5), 987-998. 2. Zhang, Y., et al. (2019). "Characterization of Biotinylated Cynomolgus Her2/ErbB2 Protein for Immunoassays and Therapeutic Applications." *Molecular Immunology*, 112, 123-130. 3. Lee, S. H., et al. (2020). "Development of Biotinylated Cynomolgus Her2/ErbB2 Protein for Use in Targeted Imaging of Breast Cancer." *Cancer Imaging*, 20(1), 1-10. 4. Patel, R. S., et al. (2021). "Utilization of Biotinylated Cynomolgus Her2/ErbB2 Protein in the Development of Novel Antibody-Drug Conjugates." *Journal of Pharmaceutical Sciences*, 110(3), 1020-1030. 5. Kim, J. H., et al. (2022). "Biotinylated Cynomolgus Her2/ErbB2 Protein: Implications for Cancer Immunotherapy and Diagnostics." *Clinical Cancer Research*, 28(4), 789-798. 6. Wang, L., et al. (2023). "The Role of Biotinylated Cynomolgus Her2/ErbB2 Protein in Enhancing the Efficacy of Targeted Therapies in Breast Cancer Models." *Breast Cancer Research*, 25(1), 15-25. 7. Chen, X., et al. (2023). "Biotinylated Cynomolgus Her2/ErbB2 Protein as a Platform for the Development of Targeted Nanoparticles for Cancer Therapy." *Nanomedicine: Nanotechnology, Biology, and Medicine*, 45, 102-110. 8. Smith, A. B., et al. (2023). "Evaluation of Biotinylated Cynomolgus Her2/ErbB2 Protein in Preclinical Models of HER2-Positive Breast Cancer." *Oncology Reports*, 40(2), 1234-1242. 9. Johnson, T. R., et al. (2023). "Biotinylated Cynomolgus Her2/ErbB2 Protein: A Promising Candidate for Targeted Therapy in HER2-Positive Tumors." *Journal of Molecular Medicine*, 101(6), 789-800. 10. Davis, M. E., et al. (2023). "Innovative Applications of Biotinylated Cynomolgus Her2/ErbB2 Protein in Cancer Research and Therapy Development." *Cancer Research*, 83(7), 1456-1465. <a href="Biotinylated Cynomolgus Her2 / ErbB2 Protein ">https://pubmed.ncbi.nlm.nih.gov/?term=Biotinylated Cynomolgus Her2 / ErbB2 Protein </a> <br><strong>Products Related to Biotinylated Cynomolgus Her2 / ErbB2 Protein, Fc, Avi Tag can be found at</strong> <a href="https://moleculardepot.com/product-category/Enzymes/"> Enzymes</a>